Naturlose Accepted By Daibetic Patients And Physicians
Naturlose, a natural sugar is found to reduce the spikes of serum Glucose that follows consumption of food and thus it has been approved as a food ingredient in US and abroad.
Naturlose has already entered phase III trial, where Spherix is currently studying the efficacy and safety of Naturlose for the treatment of diabetes. Spherix has already engaged market research companies to seek, the feedback on the likelihood of market acceptance of Naturlose. And thus assume that the phase 3 trial would be successful followed by FDA approval.
In 2 cities of U.S, Focus group testing was organized with demographically diverse groups of both general practitioner, endocrinologists, and patients ranging from the age of 30 to 70. They saw a clear role of Naturlose in the management of diabetes.
Many patients, already suffering from the side effects of oral medicines, are valuing the effects of the natural products. They also reported the convenience of the meal time dosage.
Some physicians who were using multiple drugs to control the blood sugar level were intrigued by Naturlose’s novel mechanism of action. According to them, the drug choice was very confusing for them involving Glucose level control, side effects tolerance, cost, and patient compliance. Now they are relieved to see new safe therapeutic approach. In the Focus group after testing the Naturlose, one general practitioner remarked “We are all going to start taking it“.
Source: eMaxHealth
Filed under Blood Sugar Testing, Diabetes, Diabetes Drug, Heart
